Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis

Completed · Not applicable · Has a placebo group

Conditions studied: Psoriasis

In brief

This is a 12 week bilateral study, consisting of 6 weeks of treatment and 6 weeks of follow-up. The purpose of the study is to compare the safety and effectiveness of combining and then following a high potency topical corticosteroid treatment with LCD treatment for moderate-to-severe localized plaque psoriasis.

Key facts

Study ID

NCT00769184

Run by

NeoStrata Company, Inc.

People needed

15

Starts

2008-10-01

Expected to finish

2009-04-01

Last updated by the study team

2015-08-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age or older
• able to provide written informed consent
• able to attend study visits, apply medications, and follow instructions
• moderate to severe localized plaque psoriasis lesions (<10% BSA on each side of the body)

You may not qualify if…

• other current treatments for psoriasis
• hypersensitivity to steroids, liquor carbonis detergens, alcohol, fragrance
• pregnant or nursing

Where it is running

• Windsor Dermatology — East Windsor, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.